Ajooni Biotech : Record Date

AJOONI BIOTECH LIMITED

Regd. Office: D-118, Industrial Area, Phase VII, Mohali-160055 (Pb.)

Phone: [phone] Website: www.ajoonibiotech.com

E-mail:[e-mail]/[e-mail]

CIN: L85190PB2010PLC040162

21st November, 2022

To,

National Stock Exchange of India Ltd

Exchange Plaza, Plot no. C/1, G Block,

Bandra-Kurla Complex, Bandra (E)

Mumbai - 400051

Re: Symbol: Ajooni

Subject: Regulation 30 and 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (the "SEBI Listing Regulations")

Dear Sir,

This is in furtherance to our intimation on the outcome of the meeting of the Board of Directors of the Company ("Board") held on 17th October, 2022 approving the issue of fully paid -up equity shares of face value of Rs. 2 each ("Equity Shares") of the Company, by way of a rights issue to the eligible shareholders of the Company for an amount not exceeding Rs. 30.00 Crores ("the Issue"), in accordance with applicable laws, including the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended, read with the relevant circulars issued by the SEBI, in this regard, from time to time (hereinafter referred to as "SEBI ICDR Regulations" and the issue "Rights Issue").

This is to inform you that the Right Issue Committee in its meeting held today, i.e., 21st November, 2022, has fixed the record date for the purpose of determining the shareholders who will be eligible to apply for the Rights Issue as 25th November, 2022.

The Committee also approved the following schedule for the Rights Issue:

________________________________________________________________________

Works: G,T, Road, Khanna- 141401 (Punjab) INDIA

Sr.	Particulars		Details
No.
1	Type of securities proposed to be	Fully paid-up Equity Shares of face
	Issued		value of Rs. 2/- each ("Rights Equity
			Shares")
2	Type of Issuance		Rights Issue of fully paid-up Equity
			Shares
3	Total number	of securities	4,83,60,313 fully paid-up Equity
	proposed to be issued		Shares of face value of Rs. 2/- each
			at an Issue Price of Rs. 6 per Equity
			Share aggregating to Rs. 2,901.62
			Lacs.
4	Issue Price		Rs. 6.00/- per Rights Equity Share
5	Record Date		25th November, 2022 for the purpose of
			determining the	equity	shareholders
			entitled to receive the rights entitlement
			in the Rights Issue ("Eligible Equity
			Shareholders")
6	Right Issue Period		Rights Issue Opening Date: 07th
			December, 2022
			*Last Date of Market Renunciations:
			09th December, 2022
			**Rights	Issue	Closing	Date:	15th
			December, 2022
			*Eligible	Equity	Shareholders	are
			requested to ensure that renunciation
			through	off-market	transfer	is
			completed in such a manner that the
			Rights Entitlements are credited to the
			demat account of the Renouncee(s) on
			or prior to the Issue Closing Date.

**Our Board or a duly authorized committee thereof will have the right to extend the Issue period as it may determine from time to time but not exceeding 30 (thirty) days from the Issue Opening Date (inclusive of the Issue Opening Date). Further, no withdrawal of Application shall be permitted by any Applicant after the Issue Closing Date.

7 Rights Entitlement (RE) Ratio 29 (Twenty Nine) Equity Share for every 30 (Thirty) Equity Share held by Eligible Equity Shareholders in the Company as on the record date with the right to renounce.

Sr.		Particulars			Details
No.
8		Outstanding Equity Shares prior to	5,00,27,910 fully paid-up Equity
		the Rights Issue			Shares of face value of Rs. 2/- each
9		Outstanding Equity Shares	post	9,83,88,223 fully paid-up Equity
		Rights	Issue	(assuming	full	Shares of face value of Rs. 2/- each
		subscription)
10		Terms of Payment			Full amount of Rs. 6.00 per Equity
						Share is payable on application.

The detailed terms of the Rights 1ssue including the procedure for applying in the Rights Issue and fractional entitlements will be specified in the Letter of Offer which will be filed by the Company with National Stock Exchange of India Limited ("NSE") for record purpose only.

This intimation is issued in terms of Regulation 30 and 42 of SEBI Listing Regulations.

The meeting commenced at 03:00 PM and concluded at 04:00 PM.

You are requested to take the information on record and oblige.

Thanking you,

Yours faithfully,

For Ajooni Biotech Limited

Name: Jasjot Singh

Designation: Managing Director

DIN: 01937631

SWATI VIJAN

Digitally signed by SWATI VIJAN Date: 2022.11.21 17:37:39 +05'30'